Cases
GT Biopharma, Inc. v. Emprey Asset Master Ltd. et al
as 1:2018cv06910
Defendant: Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, Emprey Tax Efficient. L.P., Emprey Tax Efficient II, L.P. and others
Plaintiff: GT Biopharma and GT Biopharma, Inc.
Cause Of Action: 15 U.S.C. ยง 78

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?